Register Today to Attend SITC 2021 in November
Registration is now open for the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021)! SITC 2021 takes place Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Click here to register.
For more information about attending SITC 2021 in person and virtually, visit the FAQ page.
SITC Wants Your Cutting-Edge Research
SITC is now accepting submissions of regular abstracts, late-breaking abstract applications, and Young Investigator Award abstracts through July 29, 2021. All accepted 36th Annual Meeting abstracts will be published as a supplement in the Journal for ImmunoTherapy of Cancer (JITC), the society’s global, open access, peer-reviewed journal.
For the full list of important abstract dates, information on abstract categories, guidelines and procedures, FAQ, or to submit your abstract, please visit https://www.sitcancer.org/2021/abstracts/.
Important Dates
SITC is also accepting abstracts through July 22 for two additional programs. See below for more information about the Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop and the Cytokines in Cancer Immunotherapy Workshop.
Exhibiting and Sponsorship
SITC offers a number of ways to promote your product or service. SITC 2021 will be presented as a hybrid meeting, which means we have innovative in-person and virtual solutions to meet your marketing and branding needs.
Contact development@sitcancer.org or (414) 271-2456 for more information and to discuss customization options.

Sparkathon Accelerator: Emerging Leaders Igniting Innovation
SITC is pleased to announce the reinvigoration of the SITC Sparkathon Accelerator, the society’s innovative program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy.
This two-year program will kick off with an in-person retreat Nov. 9–10, 2021, prior to SITC 2021, in Washington, D.C. Sparkathon Class of 2021 participants will present their research on this year’s chosen topic of mechanisms of resistance to peers and luminaries in this area of the field. Participants will learn from each other and receive guidance from the experts in a synergistic and intimate environment.
In addition to addressing hurdles that mechanisms of resistance pose to the field, SITC’s Sparkathon Accelerator explores topics specifically designed for emerging leaders in the cancer immunotherapy field. Applications are due by July 26, 2021, at 8 p.m. EDT.
Apply to Attend New Clinical Trial Protocol Development Workshop
Apply to attend SITC’s new
Clinical Immuno-Oncology Network (SCION) Workshop, taking place Jan. 23–28, 2022, in Austin, Texas, at the AT&T Hotel and Conference Center. Selected participants will develop a full cancer immunotherapy clinical trial protocol through small-group work with guidance from expert faculty during the five-day program.
13.751 Impact Factor
The Journal for ImmunoTherapy of Cancer (JITC) increased its impact factor to 13.751 on June 30, 2021. JITC’s Impact Factor makes JITC the highest ranked fully open access immunology journal and places it in the top 5 percent of all journals published in the category of immunology and top 7 percent in the category of oncology.
Published in the annual Journal Citation Reports (JCR), the latest JITC impact factor is a calculation determined on the number of 2020 citations accumulated for JITC manuscripts published in 2018 and 2019. Other valuable journal metrics for JITC may be found on the journal website.
Register Now for SITC Fall Programs
Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop
Sept. 29–30, 2021 · San Diego · Register Now · Program Schedule
Program Organizers
- Samir M. Hanash, MD, PhD – The University of Texas MD Anderson
- Avery D. Posey Jr., PhD – University of Pennsylvania School of Medicine
Abstracts are now being accepted for the Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop. Please submit your abstracts by 5 p.m. EDT on July 22, 2021.
Bispecific T cell Engagers Workshops
Sept. 30–Oct. 1, 2021 · San Diego · Register Now· Program Schedule
Program Organizers
- Elizabeth Budde, MD, PhD – City of Hope
- Daniel S. Chen, MD, PhD – IGM Biosciences, Inc.
- James L. Gulley, MD, PhD, FACP – National Cancer Institute
Cytokines in Cancer Immunotherapy Workshop
Oct. 11–12, 2021 · New York · Register Now · Program Schedule
Program Organizers
- Susan M. Kaech, PhD – Salk Institute
- Anne O' Garra, PhD – The Francis Crick Institute
- Aaron Ring, MD, PhD– Yale University
Abstracts are now being accepted for the Cytokines in Cancer Immunotherapy Workshop. Please submit your abstracts by 5 p.m. EDT on July 22, 2021.